Two-phase treatment of inflamatory candidiasis of vulva
The purpose of this prospective study was to examine successfulnes of applaying two-phase treatment of vulvar inflamatory candidiasis. At the initial phase antimycotic izokonazol 1% nitrate in combination with corticosteriod diflucorton valerate (Travocort, Schering AG, Germany) was localy applied,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Association of Zenica-Doboj Canton
2006-02-01
|
| Series: | Medicinski Glasnik |
| Subjects: | |
| Online Access: | http://www.ljkzedo.com.ba/medglasnik/vol31/Med_4_6.pdf |
| Summary: | The purpose of this prospective study was to examine successfulnes of applaying two-phase treatment of vulvar inflamatory candidiasis. At the initial phase antimycotic izokonazol 1% nitrate in combination with corticosteriod diflucorton valerate (Travocort, Schering AG, Germany) was localy applied, and then pure antimycotic izoconasol nitrate (Travogen, Schering AG, Germany). Parametars that have been analyzed in the first phase of treatment were regression of inflamatory changes of vulva, and in the second phase healing of fungal disease. Two-phase treatment of vulvar inflamatory candidiasis showed full therapy benefit at cured patients. The initial short-term local application of combination corticosteroid and antimycotic showed almost a hundred percent regression of inflamatory changes and simptoms of vulvar inflamatory candidiasis, without any side-effects noted. |
|---|---|
| ISSN: | 1840-0132 1840-2445 |